{"preliminary_commentary":{"by_channel":{"x_thread":3},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this."},"free_build":{"available":false},"commentary_summary":null,"drugs_tested":null,"indication":null,"name":"NCT03678025","nct_id":"NCT03678025","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=nct03678025. The price is an estimate of verified statements from the commentary indexed so far. Final coverage is set when the report is built. You never pay more than quoted: if the report is delivered at a smaller size, you pay that size's price, and anything paid above it is refunded. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_rule":"Never more than quoted: the buyer pays the smaller of price_usd and the price the delivered edition is sold at.","price_usd":750,"size":"focused","size_rule":"Focused: 1–150 verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":null,"arms":[{"description":"Participants receive 1 acceptable form of SST as in Induction except for treatment with docetaxel and prednisone.","label":"Arm I (SST)","type":"ACTIVE_COMPARATOR"},{"description":"Participants receive 1 acceptable form of SST as in Induction except for treatment with docetaxel and prednisone. Participants undergo prostatectomy within 8 weeks after randomization or radiation therapy within 4 weeks of randomization.","label":"Arm II (SST, prostatectomy or radiation therapy)","type":"EXPERIMENTAL"},{"description":"Standard treatment data collection prior to randomization","label":"Step 1 (pre-randomization)","type":"ACTIVE_COMPARATOR"}],"collaborators":["National Cancer Institute (NCI)"],"completion_date":{"date":"2036-10-01","type":"ESTIMATED"},"conditions":["Castration Levels of Testosterone","Metastatic Prostatic Adenocarcinoma","Stage IV Prostate Cancer AJCC v8","Stage IVA Prostate Cancer AJCC v8","Stage IVB Prostate Cancer AJCC v8"],"enrollment":{"count":1273,"type":"ESTIMATED"},"has_results":false,"interventions":[{"name":"Abiraterone","otherNames":["CB 7598"],"type":"DRUG"},{"name":"Bicalutamide","otherNames":["Casodex","Cosudex","ICI 176,334","ICI 176334"],"type":"DRUG"},{"name":"Degarelix","otherNames":["FE200486","Firmagon"],"type":"DRUG"},{"name":"Docetaxel","otherNames":["Docecad","RP56976","Taxotere","Taxotere Injection Concentrate"],"type":"DRUG"},{"name":"Flutamide","otherNames":["4'-Nitro-3'-trifluoromethylisobutyranilide","Apimid","Cebatrol","Chimax","Cytomid","Drogenil","Euflex","Eulexine","Flucinom","Flucinome","Flugerel","Fluken","Flulem","FLUT","Fluta-Gry","Flutabene","Flutacan","Flutamex","Flutamin","Flutan","Flutaplex","Fugerel","Grisetin","Niftolide","Oncosal","Profamid","Propanamide, 2-Methyl-N-(4-nitro-3-(trifluoromethyl)phenyl)-","Prostacur","Prostadirex","Prostica","Prostogenat","SCH 13521","Tafenil","Tecnoflut","Testotard"],"type":"DRUG"},{"name":"Goserelin Acetate","otherNames":["ZDX","Zoladex"],"type":"DRUG"},{"name":"Histrelin Acetate","otherNames":["Supprelin","Vantas"],"type":"DRUG"},{"name":"Leuprolide Acetate","otherNames":["A-43818","Abbott 43818","Abbott-43818","Carcinil","Depo-Eligard","Eligard","Enanton","Enantone","Enantone-Gyn","Ginecrin","LEUP","Leuplin","Leuprorelin Acetate","Lucrin","Lucrin Depot","Lupron","Lupron Depot","Lupron Depot-3 Month","Lupron Depot-4 Month","Lupron Depot-Ped","Procren","Procrin","Prostap","TAP-144","Trenantone","Uno-Enantone","Viadur"],"type":"DRUG"},{"name":"Nilutamide","otherNames":["Anandron","Nilandron","RU-23908"],"type":"DRUG"},{"name":"Orchiectomy","otherNames":["Castration","Male Castration","Male Gonadectomy","orchidectomy"],"type":"PROCEDURE"},{"name":"Prednisone","otherNames":[".delta.1-Cortisone","1, 2-Dehydrocortisone","Adasone","Cortancyl","Dacortin","DeCortin","Decortisyl","Decorton","Delta 1-Cortisone","Delta-Dome","Deltacortene","Deltacortisone","Deltadehydrocortisone","Deltasone","Deltison","Deltra","Econosone","Lisacort","Meprosona-F","Metacortandracin","Meticorten","Ofisolona","Orasone","Panafcort","Panasol-S","Paracort","PRED","Predicor","Predicorten","Prednicen-M","Prednicort","Prednidib","Prednilonga","Predniment","Prednisonum","Prednitone","Promifen","Servisone","SK-Prednisone"],"type":"DRUG"},{"name":"Quality-of-Life Assessment","otherNames":["Quality of Life Assessment"],"type":"OTHER"},{"name":"Radiation Therapy","otherNames":["Cancer Radiotherapy","Irradiate","Irradiated","irradiation","Radiation","Radiotherapeutics","RADIOTHERAPY","RT","Therapy, Radiation"],"type":"RADIATION"},{"name":"Radical Prostatectomy","otherNames":["Prostatovesiculectomy"],"type":"PROCEDURE"},{"name":"Triptorelin","otherNames":["6-D-Tryptophan-LH-RH","6-D-Tryptophanluteinizing Hormone-releasing Factor","AY-25650","CL-118,532","Decapeptyl","Detryptoreline"],"type":"DRUG"}],"last_update":"2026-10-08","lead_sponsor":"SWOG Cancer Research Network","official_title":"Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer","overall_status":"RECRUITING","phases":["PHASE3"],"primary_completion_date":{"date":"2033-04-01","type":"ESTIMATED"},"primary_outcomes":[{"measure":"Overall survival (OS)","timeFrame":"From date of randomization to date of death due to any cause, assessed up to 8 years"}],"references":[],"start_date":{"date":"2018-09-24","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer","url":"https://clinicaltrials.gov/study/NCT03678025"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.2","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/nct03678025"}